Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07398469
Eligibility Criteria:
Key Inclusion Criteria:
* Participants with a prescription for zuranolone via Accredo Specialty Pharmacy.
* Recent pregnancy in the last 12 months.
* Confirmed diagnosis of PPD.
* Able to complete the questionnaires by themselves in English.
Key Exclusion Criteria:
* Prior fill of zuranolone or brexanolone in last 12 months.
* Participants who have taken 1 or more doses of zuranolone at the time of study screening.
* Current or history of bipolar disorder.
* Failure to complete baseline (Day 0) surveys.
* Declined to consent.
* Pregnancy that ended more than 12 months ago.
Note: Other protocol-defined Inclusion/Exclusion criteria may apply.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT07398469
Study Brief:
Protocol Section:
NCT07398469